2-MMC Stats & Data

2-Methylmethcathinone emerged as a novel psychoactive substance during the mid-2010s wave of synthetic cathinone proliferation. The compound was first identified by Swedish authorities in 2014, representing one of the later positional isomers of mephedrone to appear on the recreational drug market. Following its initial detection in Sweden, 2-MMC subsequently spread to other European countries, with reports of its presence emerging from Poland and Spain. As a structural relative of the more widely known mephedrone (4-MMC) and 3-methylmethcathinone (3-MMC), 2-MMC appeared during a period when cathinone derivatives were being systematically explored by clandestine chemists seeking legal alternatives to controlled stimulants. The compound has remained relatively obscure compared to its positional isomers, which gained greater prominence in both recreational use and regulatory attention.

Effects aggregated from 4 experience reports (4 single-substance Erowid)

Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

Too few reports for bars: these effects come from 4 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

Most common forms and preparations, as a share of the 4 reports that give one

Too few reports for bars: these forms come from 4 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

• Powder / Crystals 4 of 4